Cancer statistics, 2015

05 Jan 2015Rebecca L. Siegel MPH, Kimberly D. Miller MPH, Ahmedin Jemal DVM, PhD

A total of 1,658,370 new cancer cases and 589,430 cancer deaths are projected to occur in the United States in 2015. During the most recent 5 years for which there are data (2007-2011), delay-adjusted cancer incidence rates (13 oldest SEER registries) declined by 1.8% per year in men and were stable in women, while cancer death rates nationwide decreased by 1.8% per year in men and by 1.4% per year in women. The overall cancer death rate decreased from 215.1 (per 100,000 population) in 1991 to 168.7 in 2011, a total relative decline of 22%.

Meta Analysis
18 effects
4 years
2247800 subjects

Reported Outcomes

DeterminantsOutcomeDetails

Prostate Cancer Reproductive outcome
Prostate Cancer
Reproductive system

Mortality Musculoskeletal outcome
Minor increase risk of Mortality
Musculoskeletal system

High evidence
0.9%

Central Nervous System Cancer Brain outcome

Mortality Musculoskeletal outcome
Increased risk of Mortality
Musculoskeletal system

High evidence
65.0%

Breast Cancer Reproductive outcome
Breast Cancer
Reproductive system

Mortality Musculoskeletal outcome
Minor increase risk of Mortality
Musculoskeletal system

High evidence
9.0%

Colorectal Cancer Digestive outcome
Colorectal Cancer
Digestive system

Mortality Musculoskeletal outcome
Increased risk of Mortality
Musculoskeletal system

High evidence
35.0%

Thyroid cancer Endocrine outcome
Thyroid cancer
Endocrine system

Mortality Musculoskeletal outcome
Minor increase risk of Mortality
Musculoskeletal system

High evidence
1.9%

Oesophagus cancer Digestive outcome
Oesophagus cancer
Digestive system

Mortality Musculoskeletal outcome
Increased risk of Mortality
Musculoskeletal system

High evidence
80.0%

Multiple Myeloma Blood Cancer Lymphatic outcome
Multiple Myeloma Bloo...
Lymphatic system

Mortality Musculoskeletal outcome
Increased risk of Mortality
Musculoskeletal system

High evidence
53.0%

Leukemia Lymphatic outcome
Leukemia
Lymphatic system

Mortality Musculoskeletal outcome
Increased risk of Mortality
Musculoskeletal system

High evidence
40.0%

Kidney Cancer Urinary outcome
Kidney Cancer
Urinary system

Mortality Musculoskeletal outcome
Minor increase risk of Mortality
Musculoskeletal system

High evidence
26.0%

Non-Hodgkin lymphoma Lymphatic outcome
Non-Hodgkin lymphoma
Lymphatic system

Mortality Musculoskeletal outcome
Increased risk of Mortality
Musculoskeletal system

High evidence
29.0%

Larynx cancer Respiratory outcome
Larynx cancer
Respiratory system

Mortality Musculoskeletal outcome
Minor increase risk of Mortality
Musculoskeletal system

High evidence
27.0%

Lung cancer Respiratory outcome
Lung cancer
Respiratory system

Mortality Musculoskeletal outcome
Increased risk of Mortality
Musculoskeletal system

High evidence
82.0%

Ovary cancer Reproductive outcome
Ovary cancer
Reproductive system

Mortality Musculoskeletal outcome
Increased risk of Mortality
Musculoskeletal system

High evidence
55.0%

Uterine Cancer Reproductive outcome
Uterine Cancer
Reproductive system

Mortality Musculoskeletal outcome
Increased risk of Mortality
Musculoskeletal system

High evidence
70.0%

Skin cancer Intergumentary outcome
Skin cancer
Intergumentary system

Mortality Musculoskeletal outcome
Minor increase risk of Mortality
Musculoskeletal system

High evidence
7.0%

Oral cavity and pharynx cancer Digestive outcome
Oral cavity and phary...
Digestive system

Mortality Musculoskeletal outcome
Increased risk of Mortality
Musculoskeletal system

High evidence
34.0%

Pancreatic cancer Digestive outcome
Pancreatic cancer
Digestive system

Mortality Musculoskeletal outcome
Increased risk of Mortality
Musculoskeletal system

High evidence
93.0%

Stomach cancer (Gastric cancer) Digestive outcome
Stomach cancer (Gastr...
Digestive system

Mortality Musculoskeletal outcome
Increased risk of Mortality
Musculoskeletal system

High evidence
71.0%